Design of Online Healthcare Systems
A.Suresh Kumar1, S.Fabiyola Kavitha2
1A.Suresh Kumar, Research Scholar, Bharath Institue of Higher Eduction and Research, Chennai India.
2Dr. S. Fabiyolakavitha, Mba., M.Phil., Pgdhrm., Net., Ph.D., Associate Professor, Bharath Institute of Higher Education and Research, Chennai, India.
Manuscript received on 15 September 2019 | Revised Manuscript received on 23 September 2019 | Manuscript Published on 11 October 2019 | PP: 1149-1150 | Volume-8 Issue-11S September 2019 | Retrieval Number: K123209811S19/2019©BEIESP | DOI: 10.35940/ijitee.K1232.09811S19
Open Access | Editorial and Publishing Policies | Cite | Mendeley | Indexing and Abstracting
© The Authors. Blue Eyes Intelligence Engineering and Sciences Publication (BEIESP). This is an open-access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Abstract: Medical Representatives play a major role in pharmaceutical industries in terms of promoting pharmaceutical products to the physicians. The role of physicians in deciding the therapy is still dominant, but in some areas like OTC brands, patients have more and more power to choose between the products. Other important target customers are the pharmacists, hospitals, wholesalers, governmental forces and so on. Pharmaceutical companies direct their medical representatives’ efforts towards physicians. The medical representatives efforts directed at physicians comprise personal selling through representatives’ detailing; sampling (provision of drugs at free of cost); physician meetings and events; advertisements in medical journals; conducting CME/RTM also. The new trends of pharmaceutical marketing are affected by the trends of the pharmaceutical industry itself. The number of new innovative drugs is less and less in connection with the increasing R&D (Research & Development) costs. The development cost of a new drug (including the research cost of the unsuccessful substances) is around 800 million USD. According to industry experts, R&D is no longer the industry’s driving force for growth. Even if the new drug is more effective and has less side effect (this is the pivotal elemental of the drug’s quality) than the other ones available in the market that is not the only factor which its success. To remain profitable, for a drug producer, developing its marketing activity of medical representatives may be the key of success..
Keywords: Medical Representatives, Pharmaceutical Companies, marketing efforts & Physicians.
Scope of the Article: Healthcare Informatics